Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × Metronidazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4 Rectal Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1 Pilonidal Sinus 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, B-Cell 1 Head and Neck Neoplasms 1 Colonic Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Fluorouracil 78 Leucovorin 71 Oxaliplatin 69 Irinotecan 68 Bevacizumab 43 Capecitabine 36 Cetuximab 34 Panitumumab 15 Folfox protocol 14 Chemotherapy, Adjuvant 11 Floxuridine 10 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 IFL protocol 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 Nivolumab 7 XELOX 6 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 tislelizumab 4 Trifluridine 4 S 1 (combination) 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04312360 2023-09-07

MEFO

Zealand University Hospital

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡